CORT Stock Summary and Trading Ideas (Corcept Therapeutics | NASDAQ:CORT)

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Corcept Therapeutics trades on the NASDAQ stock market under the symbol CORT.

As of April 18, 2024, CORT stock price declined to $22.66 with 920,032 million shares trading.

CORT has a beta of 0.66, meaning it tends to be less sensitive to market movements. CORT has a correlation of 0.02 to the broad based SPY ETF.

CORT has a market cap of $2.35 billion. This is considered a Mid Cap stock.

Last quarter Corcept Therapeutics reported $135 million in Revenue and $.28 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.02.

In the last 3 years, CORT stock traded as high as $34.28 and as low as $15.83.

The top ETF exchange traded funds that CORT belongs to (by Net Assets): IJR, VTI, VB, IWM, FBT.

CORT has underperformed the market in the last year with a price return of +2.3% while the SPY ETF gained +22.2%. CORT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.4% and -9.5%, respectively, while the SPY returned +5.2% and -2.6%, respectively.

CORT support price is $22.42 and resistance is $23.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CORT stock will trade within this expected range on the day.